Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Disease and Therapy Review:Major Depressive Disorder

Timely Data Resources, Inc.
September 1, 2009
16 Pages - Pub ID: TDR2428140
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


The Major Depressive Disorder Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the depression market, as well as sales of leading drugs and therapies are provided.

Additional Information

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.

Related Reports:
Snapshots US Pharmaceuticals 2009
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Pharmaceuticals Industry Report
Pharmaceutical Industry in Mexico
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
Antipsychotics Market Forecast
Substance Abuse & Mental Health Clinics in the US - Industry Market Research Report
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Psychiatric Hospitals in Australia - Industry Risk Rating Report
Prescription Drug Wholesaling in the US - Industry Risk Rating Report

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 4